No Data
No Data
Express News | Cytokinetics to Announce Third Quarter Results on November 6, 2024
B.Riley Financial Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $92
Possible Bearish Signals With Cytokinetics Insiders Disposing Stock
Oppenheimer Buy-rated Ideas: BSX, MDT, and One Hold: CYTK
A Quick Look at Today's Ratings for Cytokinetics(CYTK.US), With a Forecast Between $72 to $120
Express News | Cantor Fitzgerald Reiterates Overweight on Cytokinetics
章允量 :
103677010 : noted